BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 24479866)

  • 21. A rare occurrence of non-classic congenital adrenal hyperplasia and type 1 diabetes mellitus in a girl with Prader-Willi Syndrome: Case report and review of the literature.
    Aureli A; Bocchini S; Mariani M; Crinò A; Cappa M; Fintini D
    Front Endocrinol (Lausanne); 2023; 14():1148318. PubMed ID: 37124733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Identification of a cryptic 1p36.3 microdeletion in a patient with Prader-Willi-like syndrome features].
    Xu F; Cheng DH; Di YF; Tan K; Li LY; Lu GX; Tan YQ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Oct; 27(5):524-9. PubMed ID: 20931530
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carbohydrate metabolism is not impaired after 3 years of growth hormone therapy in children with Prader-Willi syndrome.
    L'Allemand D; Eiholzer U; Schlumpf M; Torresani T; Girard J
    Horm Res; 2003; 59(5):239-48. PubMed ID: 12714788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adult patients with Prader-Willi syndrome: clinical characteristics, life circumstances and growth hormone secretion.
    Partsch CJ; Lämmer C; Gillessen-Kaesbach G; Pankau R
    Growth Horm IGF Res; 2000 Apr; 10 Suppl B():S81-5. PubMed ID: 10984259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endocrine phenotype of 6q16.1-q21 deletion involving SIM1 and Prader-Willi syndrome-like features.
    Izumi K; Housam R; Kapadia C; Stallings VA; Medne L; Shaikh TH; Kublaoui BM; Zackai EH; Grimberg A
    Am J Med Genet A; 2013 Dec; 161A(12):3137-43. PubMed ID: 24038875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of alterations in carbohydrate metabolism in children with Prader-Willi syndrome.
    Krochik AG; Ozuna B; Torrado M; Chertkoff L; Mazza C
    J Pediatr Endocrinol Metab; 2006 Jul; 19(7):911-8. PubMed ID: 16995571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mild developmental delay and obesity in two patients with mosaic 1p36 deletion syndrome.
    Shimada S; Maegaki Y; Osawa M; Yamamoto T
    Am J Med Genet A; 2014 Feb; 164A(2):415-20. PubMed ID: 24311364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disorders of glucose metabolism in Prader-Willi syndrome: Results of a multicenter Italian cohort study.
    Fintini D; Grugni G; Bocchini S; Brufani C; Di Candia S; Corrias A; Delvecchio M; Salvatoni A; Ragusa L; Greggio N; Franzese A; Scarano E; Trifirò G; Mazzanti L; Chiumello G; Cappa M; Crinò A;
    Nutr Metab Cardiovasc Dis; 2016 Sep; 26(9):842-7. PubMed ID: 27381990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of growth hormone therapy on glucose metabolism and insulin sensitivity indices in prepubertal children with Prader-Willi syndrome.
    Crinò A; Di Giorgio G; Manco M; Grugni G; Maggioni A
    Horm Res; 2007; 68(2):83-90. PubMed ID: 17337902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of 4 genes between chromosome 15 breakpoints 1 and 2 and behavioral outcomes in Prader-Willi syndrome.
    Bittel DC; Kibiryeva N; Butler MG
    Pediatrics; 2006 Oct; 118(4):e1276-83. PubMed ID: 16982806
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A case of an atypically large proximal 15q deletion as cause for Prader-Willi syndrome arising from a de novo unbalanced translocation.
    Hickey SE; Thrush DL; Walters-Sen L; Reshmi SC; Astbury C; Gastier-Foster JM; Atkin J
    Eur J Med Genet; 2013 Sep; 56(9):510-4. PubMed ID: 23856564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Physiological adaptation after a 12-week physical activity program for patients with Prader-Willi syndrome: two case reports.
    Amaro AS; Teixeira MC; de Mesquita ML; Rodrigues GM; Rubin DA; Carreiro LR
    J Med Case Rep; 2016 Jun; 10(1):181. PubMed ID: 27339289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A case with 47,XXY,del(15)(q11;q13) karyotype associated with Prader-Willi phenotype.
    Rego A; Coll MD; Regal M; Guitart M; Escudero T; García-Mayor RV
    Horm Res; 1997; 48(1):44-6. PubMed ID: 9195210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin resistance and obesity-related factors in Prader-Willi syndrome: comparison with obese subjects.
    Talebizadeh Z; Butler MG
    Clin Genet; 2005 Mar; 67(3):230-9. PubMed ID: 15691361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new case of interstitial 6q16.2 deletion in a patient with Prader-Willi-like phenotype and investigation of SIM1 gene deletion in 87 patients with syndromic obesity.
    Varela MC; Simões-Sato AY; Kim CA; Bertola DR; De Castro CI; Koiffmann CP
    Eur J Med Genet; 2006; 49(4):298-305. PubMed ID: 16829351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Prader-Willi syndrome: a study of 40 patients and a review of the literature.
    Bray GA; Dahms WT; Swerdloff RS; Fiser RH; Atkinson RL; Carrel RE
    Medicine (Baltimore); 1983 Mar; 62(2):59-80. PubMed ID: 6338343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Self-induced cutaneous lesions in Prader-Willi syndrome].
    Plantin P; Milochau P; Broussine L; Blondin G
    Ann Dermatol Venereol; 1997; 124(5):390-2. PubMed ID: 9739896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interstitial 6q deletion and Prader-Willi-like phenotype.
    Stein CK; Stred SE; Thomson LL; Smith FC; Hoo JJ
    Clin Genet; 1996 Jun; 49(6):306-10. PubMed ID: 8884080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two patients with chromosome 22q11.2 deletion presenting with childhood obesity and hyperphagia.
    Bassett JK; Chandler KE; Douzgou S
    Eur J Med Genet; 2016 Aug; 59(8):401-3. PubMed ID: 27184501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deletions of proximal 15q without Prader-Willi syndrome.
    Greenberg F; Ledbetter DH
    Am J Med Genet; 1987 Dec; 28(4):813-20. PubMed ID: 3688019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.